90.75
2.53 (2.87%)
2.53 (2.87%)
Upgrade to Real-Time
Afterhours
Low
63.22
High
90.86
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Novo Nordisk | NVO | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 2.53 | 2.87% | 90.75 | 16:39:38 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 89.62 | 89.29 | 90.86 | 90.75 | 88.22 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 13,871 | 1,653,638 | $ 90.30 | $ 149,327,907 | - | 63.22 - 90.86 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:00:00 | 48,424 | $ 90.75 | USD |
Period:
Draw Mode:
Novo Nordisk Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 208.15B | 2.29B | 2.29B | $ 20.84B | $ 6.95B | 2.96 | 29.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 1.40 | 2.09% | 03/26/21 | - | - |
Novo Nordisk News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NVO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 87.79 | 90.86 | 87.19 | 88.21 | 1,065,520 | 2.96 | 3.37% |
| 1 Month | 82.36 | 90.86 | 82.11 | 86.43 | 791,260 | 8.39 | 10.19% |
| 3 Months | 74.01 | 90.86 | 73.53 | 81.59 | 908,629 | 16.74 | 22.62% |
| 6 Months | 72.68 | 90.86 | 66.59 | 76.06 | 939,110 | 18.07 | 24.86% |
| 1 Year | 67.83 | 90.86 | 63.22 | 72.08 | 985,169 | 22.92 | 33.79% |
| 3 Years | 50.40 | 90.86 | 41.229 | 57.83 | 1,361,359 | 40.35 | 80.06% |
| 5 Years | 55.36 | 90.86 | 30.89 | 49.91 | 1,699,410 | 35.39 | 63.93% |
Novo Nordisk Description
| With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders. |
